All In MedTech

FDA Clearance Tracker · P140033-S089

The Tendril MRI lead

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 2, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 2, 2024

Approved

Time to decision

67 days

Received Apr 26, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P140033-S089
Device name
The Tendril MRI lead
Applicant location
Sylmar, CA
Received
Apr 26, 2024
Decided
Jul 2, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P140033

Device type

Device class
Class III

Every decision under product code LWP

FDA's approval statement

As written in FDA's record.

approval for a labeling update to include the findings of the SJM Brady MRI Post-Approval Study.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.